IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis
Top Cited Papers
Open Access
- 27 May 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 24 (7), 1302-1309
- https://doi.org/10.1038/leu.2010.113
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasmsLeukemia, 2010
- Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1αScience, 2009
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008
- JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and scienceLeukemia, 2008
- Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisalLeukemia, 2008
- Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithmsLeukemia, 2007
- JAK2Exon 12 Mutations in Polycythemia Vera and Idiopathic ErythrocytosisThe New England Journal of Medicine, 2007
- MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patientsBlood, 2006
- MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid MetaplasiaPLoS Medicine, 2006
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005